Skip to main content
Move the World.
Psychedelic Mushrooms Explained

Lead image © Oleksandr / Adobe Stock

Long sought out by white guys in ill-fitting earth toned striped hoodies or people going camping, magic mushrooms are now at the center of a research revolution.

The Johns Hopkins Center for Psychedelic and Consciousness Research (CPCR), which opened this past September, has been at the forefront of psychedelic mushroom research, pushing to move the drug out of Schedule I (drugs declared to have no medical value) by demonstrating its possible uses for treating addiction and depression, among other afflictions.

Come along for the ride as the Dope Science Drug Guide expands your mind, duuuuuuuudeeeeeee...

What's this "magic mushrooms" drug now?

Outside of the kitchen or grocery store, when someone asks you for shrooms, they likely mean psilocybin mushrooms. These types of psychedelic mushrooms produce, duh, psilocybin, a naturally produced psychoactive compound.

Why do people get high on this stuff?

According to PubChem, people have been using psychedelic mushrooms for spiritual experiences since before the Spanish ran roughshod over the New World. In addition to psilocybin mushrooms' potential to create spiritually meaningful experiences — which Hopkins wants to research, by the way, for all the priests and spiritual leaders reading — people just flat out enjoy the psychedelic effects they cause.

You may know the ones I'm talking about: objects and walls "breathing," patterns moving, hearing (and maybe seeing!) music like you never have before.

What's the new medical research?

Roland Griffiths, director of the CPCR, has been studying the effects of psychedelic mushrooms since 1999, including their impact on anxiety and cigarette addiction, as he told Anderson Cooper on 60 Minutes in October.

A 2016 clinical trial at NYU suggests psychedelic mushrooms may help alleviate depression and anxiety in patients with life-threatening cancer, findings backed up by reports from Hopkins and UCLA as well.

"It's remarkable," says Matthew Johson, associate director of the CPCR. "I mean, huge reductions. Statistically, these were larger than large effect sizes ... most people getting down to the 'clinically not diagnosable range.'"

While in a much more preliminary state, data from Imperial College London shows the same potential in people with treatment-resistant depression.

There's also been a growing grassroots trend of micro-dosing psilocybin for depression, anxiety, or just all-around better living, but the science isn't there yet, Johnson says. His anecdotal evidence runs the gamut from feeling energized to not really noticing much, so the jury's out.

The scientific studies all used trip-inducing doses of psychedelic mushrooms.

"The so-called 'mystical experience,' that's predictive of long-term success," Johnson says.

Psychedelic experiences may be key to psilocybin mushroom’s medicinal effects.

In 2017, researchers at Karlstad University in Sweden found that low doses of mushrooms have potential in preventing and treating excruciatingly painful cluster headaches. It's still in the preliminary stage, but people's stories are promising.

Next on the docket is research into psilocybin's potential effects on anorexia and mild cognitive impairment/Alzheimer's disease at, you guessed it, Johns Hopkins (lacrosse and shrooms: it's what Blue Jays do). The idea is to see if psilocybin's ability to reduce depression and anxiety and lead to positive life changes will work with these patients.

The promise and the pitfalls.

Griffiths and Johnson report little opposition to their psilocybin research, as long as they are doing it safely, and a quick perusal of Google seems to back that up. The data looks strong, especially for treatment of depression and anxiety. There are still special challenges researchers face when it comes to mushrooms, however.

One of the most difficult is placebo blinding: it's kind of obvious if you're tripping or not. Researchers deploy a number of methods to help get around psychedelic mushroom's noticeable impact on patients in the placebo arm of the study.

"In one study, we used a really high dose of ritalin with people who had never taken a psychedelic before," Johnson says, "and this did fool a number of people."

Rather than controlling for the substance, they can also control for the dosage. Participants could be told they may receive a low, medium, or high dose of psilocybin, without knowing which they have received.

With high doses come psychedelic experiences, and those experiences may in fact be key to psilocybin mushroom's medicinal effects. But bad trips are no joke — your correspondent knows this from experience — and researchers must ensure safety for this unique aspect of their study. (In Hopkins' parlance, they are "challenging experiences," a euphemism meant to evoke their potential for opportunity, as well.)

To prevent lasting damage, participants must be screened for a potential psychotic disorder, like schizophrenia, which can be exacerbated by psychedelic trips. Specially trained session facilitators help guide people through their trips, which is considered best practice, Johnson says.

Whether in the lab or the "bad trip" tent at Burning Man — he's done it — just having someone to talk to can make all the difference. After their experience, subjects also talk through their trip.

While there are drugs which can arrest a trip — think shroom Narcan — and benzodiazepines (like Xanax) that can make things easier, they are rarely needed in Johnson's experience.

"There are definitely risks, but there are also definitely ways to address them and mitigate those risks," Johnson says.

Up Next

Health Care
MIT Can Now Monitor Your Sleeping Position With Radio Waves
sleeping positions
Health Care
MIT Can Now Monitor Your Sleeping Position With Radio Waves
A new sleep monitor out of MIT uses reflections from radio signals — not cameras or body sensors — to track a person’s sleeping positions.

A new sleep monitor out of MIT uses reflections from radio signals — not cameras or body sensors — to track a person’s sleeping positions.

Outer Space
Signs of Life Found On Venus
signs of life on venus
Outer Space
Signs of Life Found On Venus
Scientists found the gas, phosphine, in Venus’ atmosphere. So far, the only explanation is alien life.

Scientists found the gas, phosphine, in Venus’ atmosphere. So far, the only explanation is alien life.

Aerospace
Scientists Find a New Way to Detect Space Junk Orbiting Earth
Space Junk
Aerospace
Scientists Find a New Way to Detect Space Junk Orbiting Earth
A new technique for tracking space junk with lasers works during daylight hours — making previously “invisible” space debris visible.

A new technique for tracking space junk with lasers works during daylight hours — making previously “invisible” space debris visible.

Wildfires
This Model May Help Predict Wildfires
predict wildfires
Wildfires
This Model May Help Predict Wildfires
Wildfires need dry fuel to thrive. Researchers at Stanford are working on an AI model to measure dryness to help predict, and control, the blaze.

Wildfires need dry fuel to thrive. Researchers at Stanford are working on an AI model to measure dryness to help predict, and control, the blaze.

Genetics
$100 Genome Sequencing Has Finally Arrived
genome sequencing
Genetics
$100 Genome Sequencing Has Finally Arrived
China-based genome sequencing company MGI says it can sequence a human genome for just $100, a cost that could make the service available to all.

China-based genome sequencing company MGI says it can sequence a human genome for just $100, a cost that could make the service available to all.

Dope Science
New Promise for Psychedelics and Depression
studying psychedelics and depression
Dope Science
New Promise for Psychedelics and Depression
New findings on psychedelics and depression show the benefits of microdosing, and could present more effective treatment options.
By Kurt Hackbarth

New findings on psychedelics and depression show the benefits of microdosing, and could present more effective treatment options.

Dope Science
Marijuana and Autism: Removing the Stigma
Removing the stigma of marijuana and autism
Dope Science
Marijuana and Autism: Removing the Stigma
Research is beginning to prove the hopeful connection between marijuana and autism treatment for symptom relief. Here is one man’s inspiring story.
By Kurt Hackbarth

Research is beginning to prove the hopeful connection between marijuana and autism treatment for symptom relief. Here is one man’s inspiring story.